Skip to main content
. 2017 Oct 3;6(10):e005498. doi: 10.1161/JAHA.117.005498

Table 1.

Patient Characteristics

Parameter STEMI (n=305) NSTEMI (n=461) P Value
Age, y 65 (58–72) 70 (62–75) <0.001
Sex (female) 64 (21.0) 116 (25.2) 0.190
BMI 26.6 (24.6–29.4) 27.2 (24.7–30.1) 0.082
IDDM 18 (5.9) 48 (10.4) 0.030
Arterial hypertension 227 (74.4) 373 (80.9) 0.048
Hyperlipidemia 157 (51.5) 228 (49.5) 0.563
Smoking 121 (39.7) 159 (34.5) 0.144
COPD 23 (7.5) 51 (11.1) 0.133
Peripheral arterial disease 18 (5.9) 56 (12.1) 0.004
Atrial fibrillation 18 (5.9) 48 (10.4) 0.035
LV function ≤50% 120 (39.3) 169 (36.7) 0.493
Renal impairment, (CC <50 mL/min/1.73 m²) 31 (10.2) 92 (20.0) <0.001
Renal replacement therapy 2 (0.7) 2 (0.4) 0.651
Severely reduced LV function (<30%) 18 (5.9) 21 (4.6) 0.336
EuroSCORE II (%) 4.12 (2.75–5.81) 4.58 (2.80–7.74) 0.009
Prehospital thrombolysis 43 (14.1) 3 (0.7) <0.001
IABP preoperatively 33 (10.8) 29 (6.3) 0.024
Intubated on arrival in the operating room 2 (0.7) 8 (1.7) 0.330
Continuous inotropic support 2 (0.7) 8 (1.7) 0.330
Time from diagnosis to surgery, h 5.0 (3.2–8.8) 11.7 (6.4–22.0) <0.001
Lactate, mmol/L 1.20 (0.85–1.70) 1.00 (0.80–1.40) 0.001
Lactate >2 mmol/L 58 (19.0) 46 (10.1) 0.003
Cerebrovascular event 15 (4.9) 29 (6.3) 0.430
Prior myocardial infarction 32 (10.5) 45 (9.8) 0.746
Prior cardiac surgery 3 (1.0) 8 (1.7) 0.540

Values are expressed as count (percentage) or median (range). BMI indicates body mass index; CC, creatinine clearance; COPD, chronic obstructive pulmonary disease; IABP, intra‐aortic balloon pump; IDDM, insulin‐dependent diabetes mellitus; LV, left ventricular; NSTEMI, non–ST‐segment–elevation myocardial infarction; STEMI, ST‐segment–elevation myocardial infarction.